Inflammatory Disorders

Inflammation models in the liver, lungs, kidneys, heart, etc. designed to optimize the efficacy of your drug against oedema, complement & leukocyte activation, tissue healing, and fibrosis.

Discover our most popular White papers for this area of expertise

Read it here

A strategy to develop a cardiac anti-arrhythmic drug from scratch

by Dany Salvail Ph.D., Vice-President.

Published on June 19, 2023

Read more

Translation

by Dany Salvail Ph.D., Vice-President.

Published on May 9, 2023

Read more
01 / Cardiovascular

Cardiovascular diseases

We leverage our world-class expertise on cardiovascular diseases, e.g., pulmonary arterial hypertension, myocardial infarction, hemorrhagic shock, acute kidney injury, to craft tailored protocols designed in collaboration with you.
Read More
02 / Inflammatory

Inflammatory disorders

We leverage our world-class expertise on inflammatory disorders, e.g., diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, liver fibrosis, cholestatic liver disease, to craft tailored protocols designed in collaboration with you.
Read More
03 / Respiratory

Respiratory diseases

We leverage our world-class expertise on respiratory diseases e.,g., chronic obstructive pulmonary disease, asthma, allergic rhinitis, pulmonary fibrosis, to craft tailored protocols designed in collaboration with you.
Read More
04 / Bleeding

Bleeding disorders

We leverage our world-class expertise on bleeding disorders, e.g., hemophilia, sickle cell anemia, immune thrombocytopenia, von Willebrand disease, to craft tailored protocols designed in collaboration with you.
Read More